Search Within

Heiko Schoder

  1. "Radiation Oncology, Department of"
Formats
  1. Journal Article (67)
  2. Meeting Abstract (65)
  3. Research Letter (2)
  4. Conference Paper (1)
Groups
  1. Molecular Imaging and Therapy Service (135)
  2. Radiation Oncology, Department of (135)
  3. Radiology, Department of (135)
  4. Department of Medicine (90)
  5. Survivorship Research (86)
  6. Center for Hematologic Malignancies (56)

More Groups

People
  1. Nancy Lee (65)
  2. Joachim Yahalom (50)
  3. John Humm (42)
  4. Maria Palomba (39)
  5. Ariela Noy (34)
  6. Alison Moskowitz (33)

More People

Years
  1. 2025 (4)
  2. 2024 (14)
  3. 2023 (16)
  4. 2022 (9)
  5. 2021 (11)
  6. 2020 (8)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (39)
  2. Blood (20)
  3. Journal of Clinical Oncology (14)
  4. Journal of Nuclear Medicine (9)
  5. Hematological Oncology (6)
  6. Blood Cancer Journal (3)

More Publications

Publishers
  1. Elsevier Inc. (46)
  2. American Society of Hematology (22)
  3. American Society of Clinical Oncology (14)
  4. Society of Nuclear Medicine (9)
  5. Wiley Blackwell (8)
  6. Springer (5)

More Publishers

Results (135)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor volume predicts for baseline hypoxia status in HPV related oropharyngeal carcinomas (OPC) that underwent major radiation de-escalation: The 30 Reduction in Oropharyngeal Cancer Trial
    Meeting Abstract

    Han, J.; Diplas, B.; Paudyal, R.; Oh, J. H.; Sherman, E.; Schoder, H.; Hatzoglou, V.; Yu, Y.; Wong, R. J.; Wray, R.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Predicting F-18 FMISO PET hypoxia measurements from F-18 FDG PET scan using a generative adversarial network
    Meeting Abstract

    Zhao, W.; Grkovski, M.; Lee, N.; Schoder, H.; Humm, J.; Veeraraghavan, H.; Deasy, J.
    Medical Physics (2022)

    Fulltext@MSK | Save
  • Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma
    Journal Article

    Sha, F.; Okwali, M.; Alperovich, A.; Caron, P. C.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; Khan, N.; more...
    Blood Cancer Journal (2022)

    Fulltext@MSK | Save
  • Metabolic tumor volume and total lesion glycolysis can predict response to very low dose radiotherapy (4 Gy) in indolent B-cell lymphomas
    Meeting Abstract

    Wijetunga, N. A.; Imber, B. S.; Lee, J.; Hajj, C.; Mayerhoefer, M. E.; Schoder, H.; Yahalom, J.
    Blood (2021)

    Fulltext@MSK | Save
  • Favorable outcomes of patients with limited-stage ocular adnexal DLBCL treated in the rituximab era: Long-term follow-up of a single center experience
    Meeting Abstract

    Qualls, D.; Batlevi, C. L.; Caron, P. C.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; Khan, N.; Kumar, A.; Matasar, M. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Precision radiotherapy: Reduction in radiation for oropharyngeal cancer in the 30 ROC trial
    Journal Article

    Riaz, N.; Sherman, E.; Pei, X.; Schöder, H.; Grkovski, M.; Paudyal, R.; Katabi, N.; Selenica, P.; Yamaguchi, T. N.; Ma, D.; more...
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save
  • Postoperative PET/CT for detection of early recurrence (ER) after surgery for squamous cell carcinomas (SCC) of the oral cavity (OC)
    Meeting Abstract

    Yu, Y.; Schöder, H.; Kang, J.; McBride, S. M.; Tsai, C. J.; Chen, L.; Zakeri, K.; Gelblum, D. Y.; Boyle, J.; Cracchiolo, J. R.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • The 30 ROC trial: Precision intra-treatment imaging guiding major radiation reduction in human papillomavirus related oropharyngeal cancer
    Meeting Abstract

    Lee, N. Y.; Sherman, E. J.; Schöder, H.; McBride, S. M.; Yu, Y.; Kang, J.; Tsai, C. J.; Gelblum, D. Y.; Boyle, J.; Singh, B.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Phase II trial of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Shah, G.; Schöder, H.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Ryu, S.; Sohail, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Brentuximab vedotin combined with chemotherapy in patients with newly diagnosed early-stage, unfavorable-risk Hodgkin lymphoma
    Journal Article

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, E.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Constine, L. S.; Dandapani, S. V.; Drill, E.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save